“All Isolated MVR Surgery Should Be Done Minimally Invasively”

(Adj) Professor Theo Kofidis advocates for the widespread adoption of minimally invasive mitral valve surgery (MICS) based on compelling evidence of its safety and efficacy. Drawing on studies from institutions like the Leipzig Heart Center and New York University Medical Center, he highlights that MICS offers comparable outcomes to traditional sternotomy but with advantages such as shorter hospital stays, reduced blood loss, and improved cosmetic results. Despite initial scepticism, studies demonstrate that MICS is feasible even in complex cases like obese patients or those with left ventricular dysfunction.